<DOC>
	<DOCNO>NCT00648999</DOCNO>
	<brief_summary>To demonstrate patient treated Kaletra improvement quality life compare quality life previous NRTI therapy .</brief_summary>
	<brief_title>Safety Efficacy Kaletra ARV Therapy Experienced Patients</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>HIV Infected subject Subjects fail current HIV treatment , Subjects viral load &lt; 400 copies/mL tolerate current HIV treatment . Subject currently participate another clinical study participate another clinical study within 30 day prior screen visit Subject pregnant</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Kaletra</keyword>
</DOC>